Kefir Cholesterol Lowering Pilot Study
Effect of Traditionally and Commercially Prepared Kefir on Cholesterol Levels in Adult Males With Borderline High Cholesterol Levels
1 other identifier
interventional
21
1 country
1
Brief Summary
High cholesterol (a type of fat in humans blood) may be one factor that can lead to heart disease. If people have higher cholesterol, it is possible that kefir (a food similar to yogurt) may help to control blood cholesterol levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2020
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedStudy Start
First participant enrolled
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2022
CompletedSeptember 19, 2024
January 1, 2023
1.8 years
January 22, 2020
September 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Blood Lipids following provision of each type of Kefir
Change in blood lipid panel (HDL, LDL, Total Cholesterol, Triglycerides) will be measured in blood samples.
4 weeks
Secondary Outcomes (1)
Fecal microbiota composition changes following the provision of each type Kefir
4 weeks
Study Arms (2)
Commercial Kefir
EXPERIMENTALCommercially produced kefir
Traditional Kefir
EXPERIMENTALTraditionally grown kefir
Interventions
Eligibility Criteria
You may qualify if:
- Males, aged 18-65y
- Moderately hypercholesterolemic adults: LDL-C between 3.2 and 4.9 mM, but otherwise healthy
- No history of CVD, type 2 diabetes, monogenic dyslipidemia or use of medications for hyperlipidemia (including statins).
- No dairy allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta
Edmonton, Alberta, T6G 2E1, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Both types of kefir will be flavoured the same, and visually look the same.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2020
First Posted
January 29, 2020
Study Start
July 7, 2020
Primary Completion
April 25, 2022
Study Completion
September 16, 2022
Last Updated
September 19, 2024
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share